Literature DB >> 30395824

High Density of Intratumor CD45RO+ Memory Tumor-Infiltrating Lymphocytes Predicts Favorable Prognosis in Patients With Oral Squamous Cell Carcinoma.

Chen Zhou1, Jin Li2, Yaping Wu2, Pengfei Diao2, Jianrong Yang3, Jie Cheng4.   

Abstract

PURPOSE: Although tumor-infiltrating lymphocytes (TILs) have been increasingly appreciated as novel biomarkers for prognostic prediction in cancer, little attention has been paid to the CD45RO+ memory TIL and its associations with clinical outcomes in oral squamous cell carcinoma (OSCC). The purpose of this study was to determine the associations between CD45RO+ TILs and clinicopathologic parameters and prognosis in OSCC.
MATERIALS AND METHODS: Tissue sections of primary OSCC from 2 independent tertiary referral cancer centers (Nanjing and Wuxi, China) were retrospectively collected and subjected to immunohistochemical staining for CD45RO. Densities of CD45RO+ TILs in the tumor center (CT) and invasive margin were calculated. Optimal cutoff values of CD45RO+ TILs for patient stratification were generated by X-tile software. Kaplan-Meier and Cox regression analyses were performed to assess associations between CD45RO+ TILs and overall survival and recurrence-free survival. Prognostic prediction of CD45RO+ TILs was estimated by receiver operating characteristic (ROC) curve.
RESULTS: One hundred sixty-nine eligible patients with OSCC were included. No relevant associations between CD45RO+ TILs and clinicopathologic parameters were identified. Kaplan-Meier analyses indicated that a high density of CD45RO TILs in the CT was significantly associated with favorable overall and recurrence-free survival (P = .0018 and .0007 by log-rank test). Cox proportional regression analyses showed that presence of CD45RO TILs in the CT was an independent prognostic factor for overall survival of OSCC. ROC curves showed that presence of CD45RO TILs in the CT was comparable to clinical stage in predicting patient survival, whereas their combination was superior to either parameter alone.
CONCLUSIONS: The present findings indicate that intratumor density of CD45RO TILs is a viable and independent prognostic predictor for OSCC.
Copyright © 2018 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30395824     DOI: 10.1016/j.joms.2018.09.039

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  5 in total

1.  The Prognostic and Predictive Significance of Tumor-Infiltrating Memory T Cells Is Reversed in High-Risk HNSCC.

Authors:  Rebekka Hartan; Sören Schnellhardt; Maike Büttner-Herold; Christoph Daniel; Arndt Hartmann; Rainer Fietkau; Luitpold Distel
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

2.  Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion.

Authors:  Sumiyo Saburi; Takahiro Tsujikawa; Aya Miyagawa-Hayashino; Junichi Mitsuda; Kanako Yoshimura; Alisa Kimura; Hiroki Morimoto; Gaku Ohmura; Akihito Arai; Hiroshi Ogi; Eiichi Konishi; Kyoko Itoh; Kiminori Sugino; Shigeru Hirano
Journal:  Mod Pathol       Date:  2021-12-24       Impact factor: 7.842

3.  Tumor-Infiltrating CD4+ Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma.

Authors:  Jin Wu; Tianyi Zhang; Haofeng Xiong; Liujun Zeng; Zijia Wang; Ying Peng; Weijun Chen; Xin Hu; Tong Su
Journal:  J Inflamm Res       Date:  2022-01-08

4.  Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma.

Authors:  Hideyuki Takahashi; Koichi Sakakura; Shota Ida; Reika Kawabata-Iwakawa; Toshiyuki Matsuyama; Hiroe Tada; Ikko Mito; Kazuaki Chikamatsu
Journal:  Cancer Sci       Date:  2021-11-16       Impact factor: 6.716

Review 5.  Methods to Determine and Analyze the Cellular Spatial Distribution Extracted From Multiplex Immunofluorescence Data to Understand the Tumor Microenvironment.

Authors:  Edwin Roger Parra
Journal:  Front Mol Biosci       Date:  2021-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.